National Hospital Organization Kumamoto Medical Center
About National Hospital Organization Kumamoto Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
10
Janssen Research & Development, LLC
3
Kyowa Kirin Co., Ltd.
3
Bayer
2
Eli Lilly and Company
2
Janssen Pharmaceutical K.K.
2
AM-Pharma
1
Daiichi Sankyo Co., Ltd.
1
Daiichi Sankyo, Inc.
1
Jazz Pharmaceuticals
1
MEI Pharma, Inc.
1
Clinical Trials at National Hospital Organization Kumamoto Medical Center
During the past decade, National Hospital Organization Kumamoto Medical Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 6 clinical trials were completed, i.e. on
average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
2004-11-01
2006-03-01
Unknown status
1,500
Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15
2010-07-01
2012-04-01
Completed
44
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
2011-11-01
2012-10-01
Completed
38
Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
2013-01-01
2017-04-26
Completed
49
Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients in Japan
2013-03-01
2016-01-19
Completed
26
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
2015-12-02
2021-07-26
Terminated
372
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
2016-04-25
2023-03-31
Active, not recruiting
700
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
2016-01-06
2030-04-22
Active, not recruiting
551
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Hospital Organization Kumamoto Medical Center" #1 sponsor was "Pfizer" with 10 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "Kyowa Kirin Co., Ltd." with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Eli Lilly and Company"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kumamoto Medical Center"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Asahi Kasei Medical Co., Ltd." with 1 trials as a collaborator and "Kyowa Kirin, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at National Hospital Organization Kumamoto Medical Center
According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kumamoto Medical Center" are
"Multiple Myeloma" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Prostate Cancer" (2 trials), "Abiraterone Acetate" (1 trials) and "Acute Kidney Injury Due to Sepsis" (1 trials). Many other conditions were trialed in "National Hospital Organization Kumamoto Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at National Hospital Organization Kumamoto Medical Center
Most popular intervention types in "National Hospital Organization Kumamoto Medical Center" are "Drug" (26 trials), "Biological" (5 trials), "Other" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Abemaciclib" (2 trials), "Bendamustine" (2 trials), "Best Supportive Care" (2 trials) and "Daratumumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at National Hospital Organization Kumamoto Medical Center
The vast majority of trials in "National Hospital Organization Kumamoto Medical Center" are
27 trials for "All" genders and 4 trials for "Male" genders.
Clinical Trials Status at National Hospital Organization Kumamoto Medical Center
Currently, there are NaN active trials in "National Hospital Organization Kumamoto Medical Center".
undefined are not yet recruiting,
6 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in National Hospital Organization Kumamoto Medical Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Kumamoto Medical Center, 3 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".